PHARMACOKINETICS OF ORAL IDARUBICIN IN BREAST-CANCER PATIENTS WITH REFERENCE TO ANTITUMOR-ACTIVITY AND SIDE-EFFECTS

被引：27

作者：

ELBAEK, K

EBBEHOJ, E

JAKOBSEN, A

JUUL, P

RASMUSSEN, SN

BASTHOLT, L

DALMARK, M

STEINESS, E

机构：

[1] AARHUS UNIV HOSP, INST PHARMACOL, DEPT ONCOL, DIV CLIN PHARMACOL, DK-8000 AARHUS, DENMARK

[2] FINSEN INST, DK-2100 COPENHAGEN, DENMARK

[3] ROYAL DANISH SCH PHARM, DEPT PHARMACOL, DK-2100 COPENHAGEN, DENMARK

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1989年 / 45卷 / 06期

关键词：

D O I：

10.1038/clpt.1989.83

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：627 / 634

页数：8

共 19 条

[1]

BASTHOLT L, 1987, CANCER TREAT REP, V71, P451

[2]

BERMAN E, 1983, CANCER RES, V43, P6096

[3]

CASAZZA AM, 1983, P AM ASSOC CANC RES, V24, P251

[4]

EGORIN MJ, 1987, CANCER RES, V47, P6104

[5]

GIBALDI M, 1982, PHARMACOKINETICS

[6] TIME DEPENDENCY OF ADRIAMYCIN AND ADRIAMYCINOL KINETICS [J].

GIL, P ;

FAVRE, R ;

DURAND, A ;

LIADIS, A ;

CANO, JP ;

CARCASSONNE, Y .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1983, 10 (02) :120-124

[7] PHARMACOKINETICS OF IDARUBICIN (4-DEMETHOXYDAUNORUBICIN IMI-30 NSC 256439) FOLLOWING INTRAVENOUS AND ORAL-ADMINISTRATION IN PATIENTS WITH ADVANCED CANCER [J].

GILLIES, HC ;

HERRIOTT, D ;

LIANG, R ;

OHASHI, K ;

ROGERS, HJ ;

HARPER, PG .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 23 (03) :303-310

[8] PHASE-II TRIAL WITH ORAL IDARUBICIN IN ADVANCED BREAST-CANCER [J].

LOPEZ, M ;

DILAURO, L ;

PAPALDO, P ;

LAZZARO, B ;

GANZINA, F ;

DIPIETRO, N .

INVESTIGATIONAL NEW DRUGS, 1986, 4 (01) :39-42

[9] CLINICAL-PHARMACOLOGY OF 4-DEMETHOXYDAUNORUBICIN (DMDR) [J].

LU, K ;

SAVARAJ, N ;

KAVANAGH, J ;

FEUN, LG ;

BURGESS, M ;

BODEY, GP ;

LOO, TL .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 17 (02) :143-148

[10] ACTIVITY OF 4-DEMETHOXYDAUNORUBICIN BY THE ORAL ROUTE IN ADVANCED BREAST-CANCER [J].

MARTONI, A ;

PACCIARINI, MA ;

PANNUTI, F .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (07) :803-806

← 1 2 →